A recent study led by Karolinska Institute of Sweden, indicated that an Artificial Intelligence (AI) system had considerably been proved more accurate than biopsy in terms of determining cancer & length of tumor from a sample. In addition, the AI system was as good as almost 23 leading uropathologists across the world in calculating the Gleason score, which is one of the most essential prognostic marker for the prostate cancer.
The Artificial Intelligence system for determining prostate cancer has been developed by a team that had previously launched the new blood-based prostate cancer diagnostic test called Stockholm3. Stockholm3 actually doubles the number of aggressive cancer cells identified, at the same time it also reduces number of unnecessary biopsies by almost 50 percent as compared to the existing clinical procedure with PSA. Stockholm3 is as of now been used in clinical procedures in Sweden, Finland, Norway and Denmark.
EIT (Eastern Institute of Technology) Health has aided in accelerating the development and implementation of Stockholm3 as well as the new AI system named as OncoWatch, by the means of network & financial backing. The OncoWatch will now be sent for validation in nine countries multicenter in order to assess its accuracy across different labs and in a wide-ranging digital pathology scanners, as a part of its development.
The researchers’ from the institute held that prostate cancer diagnostics demands for high-quality devices and with the new AI system that have probably proven pioneering test to the global market. The test for Stockholm3 was used in 20,000 plus men within the Nordics alone last year and OncoWatch is also expected for a strong uptake.
Prostate cancer is amongst most commonly diagnosed cancer in men especially across the Europe, with more than 450,000 new cases been reported every single year. Thus, OncoWatch will enable diagnosis followed by treatment of the aggressive prostate cancer, which is key to survival.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Severity: Warning
Message: count(): Parameter must be an array or an object that implements Countable
Filename: amp/news_details_amp.php
Line Number: 252
Backtrace:
File: /home/smartmarketnews/public_html/application/views/amp/news_details_amp.php
Line: 252
Function: _error_handler
File: /home/smartmarketnews/public_html/application/controllers/Amp_controller.php
Line: 41
Function: view
File: /home/smartmarketnews/public_html/index.php
Line: 315
Function: require_once
Smarter Decisions with Smart News
Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.
media@smartmarketnews.com | sales@smartmarketnews.com
Contact Us